PMID: 6105242Jul 12, 1980Paper

Photochemotherapy in mycosis fungoides. A study of 73 patients

Lancet
D V BriffaS S Bleehen

Abstract

Seventy-three patients with mycosis fungoides were treated with photochemotherapy and followed up for 2 to 39 months. Photochemotherapy produced clinical and histological clearing in a very high proportion of patients with stage 0 to II disease. The response in patients with tumours was less satisfactory, and a high proportion of these patients required local radiotherapy to resistant lesions. Maintenance treatment with photochemotherapy may keep many patients with stage 0 to II disease in remission for up to 3 years, but patients with advanced disease may relapse despite maintenance treatment. Patients with all stages of mycosis fungoides may relapse when maintenance treatment is withdrawn.

References

May 6, 1977·Deutsche medizinische Wochenschrift·C HofmannO Braun-Falco
Apr 12, 1979·The New England Journal of Medicine·R S SternT B Fitzpatrick
Jul 1, 1978·The British Journal of Dermatology·A Du VivierF Urbach
Jan 1, 1979·Archives of Dermatology·N J LoweC F Vickers
Aug 1, 1976·Cancer·B A GilchrestT B Fitzpatrick

❮ Previous
Next ❯

Citations

Feb 1, 1997·The Australasian Journal of Dermatology·A Watson
Apr 30, 2002·American Journal of Clinical Dermatology·Narin ApisarnthanaraxMadeleine Duvic
Nov 1, 1994·Journal of the American Academy of Dermatology·B HonigD Karp
Aug 1, 1991·Journal of the American Academy of Dermatology·A G WilsonJ D Kirby
Mar 1, 1989·Journal of the American Academy of Dermatology·E A OlsenJ Zeffren
May 11, 2006·Journal of the European Academy of Dermatology and Venereology : JEADV·F PavlotskyH Trau
May 20, 2014·Journal of the American Academy of Dermatology·Felix PavlotskyAviv Barzilai
Sep 16, 2000·The Journal of Dermatology·Y B ChoeK H Cho
Mar 10, 2015·Indian Journal of Dermatology, Venereology and Leprology·Sunil Dogra, Rahul Mahajan
Apr 28, 2004·Clinical Journal of Oncology Nursing·Pamela L Walker, Nam H Dang
Jun 1, 1988·The British Journal of Dermatology·K Thestrup-PedersenH Zachariae
May 1, 1984·Clinical and Experimental Dermatology·B E MonkA W du Vivier
Nov 1, 1990·Current Problems in Cancer·R T HoppeE A Abel
Nov 7, 2017·Journal of the European Academy of Dermatology and Venereology : JEADV·V GrandiUNKNOWN Cutaneous Lymphoma Task Force (Commissione Linfomi Cutanei) of Lymphoma Italian Foundation (Fondazione Italiana Linfomi, FIL
Dec 1, 1982·The British Journal of Dermatology·G L Wantzin, K Thomsen
Oct 1, 1984·International Journal of Dermatology·N C McFadden
Aug 2, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·R S SiegelT M Kuzel
Aug 12, 2017·Archives of Dermatological Research·Adriana PolańskaAleksandra Dańczak-Pazdrowska
Sep 13, 2008·Journal of the American Academy of Nurse Practitioners·Ella Ares
Apr 30, 2019·Frontiers in Oncology·Erica S Tarabadkar, Michi M Shinohara
Sep 28, 2021·Current Treatment Options in Oncology·Caitlin M BrumfielAaron R Mangold

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

British Medical Journal
L HodgeD Vella Briffa
Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Società Italiana Di Dermatologia E Sifilografia
R PiccinnoL Mainardi
The Journal of Dermatological Treatment
R PiccinnoSerena Percivalle
© 2021 Meta ULC. All rights reserved